top read note buysid
report highlight
top note jan includ annual burn question compani
coverag list near-term catalyst analysi crossov ipo
addit highlight add report team contain uniqu
insights/differenti view revisit
industri burn question biopharma management jan
industri what biopharma near-term catalyst jan
industri crossov ipo number keep go jan
industri final ipo scorecard metric trend jan
simpl stori path upsid jan
amrn gener case may wane jan
thought ahead pot year remain top larg cap jan
industri read yee-leav watch democrat race jan
eun yang key report host investor call
pnh expert note anemia major limit soliris/ultomiri view recent
data retain anemia improv monotherapi amaz
await full public better understand data expert see current
treat patient inadequ respond sizabl initi opportun new agent
develop maintain neutral view competit overhang
conjunct roll nda submiss provid updat
data registr endpoint pralsetinib lung cancer show orr
central review vs investig assess competitor selpercatinib dor
reach vs competitor highli encourag deepening/
prolong respons note patient identif key commerci success
roll nda submiss pralsetinib complet nda file mtc
track competitor nda selpercatinib nsclc mtc file
enrol jan expect present top-line data given
project peak sale eysuvi think stock may move
posit data near fail studi view prospect
failur seem low given two shot goal could lead posit
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
data trial enrol sever pt drive benefit
pre-report ingrezza sale q/q y/i exceed
estimate con believ sale also exceed investor
expect around also cite inventori stock contribut
partli beat second product opicapon set approv april lastli
busi dev activ continu w/ two pii-readi asset recent ad
insid addit comment amin raycroft howerton
pleas see import disclosur inform page report
second ind clear allow treatment pt r/r solid
tumor togeth anti egfr mab recal initi studi
underway treatment hematolog malign public also
highlight anti-tumor efficaci therapi lymphoma ovarian mous model
togeth mab demonstr abil cryopreserv nk cell perform on-
par fresh cell hk bispecif platform stori next-gen oncolog
therapeut initi alphamab oncolog buy rate
jan alphamab pioneer innov china biotech use proprietari
platform co develop deep portfolio bsab oncolog indic phi/
ii data could differenti landscap de-novo
biolog ascrib bsab format could break boundari market data
next mo near-term revenue oppi drive share higher
auph
takeaway select san fran meet w/ cover compani
note monday san fran includ number rare
cyrsvita kpti xpovio rtrx commerci product zlab note discuss
zejula recent china approv mainten ovarian cancer note rare
new data otcd highlight potenti upsid head event
includ pdufa add gene tx data crysvita launch expans
auph initi discuss view voclosporin differenti profil w/
likelihood get approv lupu nephriti point logc ind file mma
mtg w/ management san fran learn new perspect clinic
co strategi expect initi dose report prelim data sppi
cohort pozi data disappoint safeti signal put sbph inarigivir clinic
program hold
chri howerton key report tgtx/ct sf
podcast walk background applic clinic trial simul
provid brief overview recent tgtx unity-cl highlight
key feedback investor well bespok research exampl capabl
talk experienc litig lawyer analyz recent oral
argument on-going fda disput continu believ co unlik win
case see scenario delay develop plan lower pos/penetr w/
potenti corpor strategi met co within coverag sf recent
note nt strateg focu increment updat four note meet sf
pleas see import disclosur inform page report
top note last week
pleas see import disclosur inform page report
tickertitled burn question biopharma manag meetjanuari biopharma near-term catalyst could move januari ipo number keep go januari ipo scorecard metric trend top pjanuari stori path upsid initiajanuari could come forjanuari case may wane discuss recent azn epanovjanuari stock-mov catalyst up/down sdecemb ahead pot year remain top larg capjanuari take patienc fundament fine remain injanuari yee-leav watch democrat race paperjanuari comment remain tight-lip expectedjanuari proceed complet decis march per judgejanuari firehos amrn akrjanuari san fran takeaway srra januari one week easili summar minutesjanuari spirit upsid cf launch lot pipejanuari remain heat expert testimoni cont amrn gojanuari data updat upcom angiogenesi meet -januari row on-going trial defend hikma/reddi get tjanuari san fran takeaway crsp zlab januari thought management meet like ejanuari stretch testimoni expert ms suggest amrn ijanuari ceo confid step aheadjanuari import event come scenario treejanuari upsid potenti promis depress drujanuari row hikma/reddi request immedi rule januari approv year de-risk continu buyjanuari buy quick action less steroid new option januari strong consensu fundament track anjanuari competitor fall waysid leav ger fisjanuari updat support cont posit thesi buyjanuari approv sign execut unlock larg market fodecemb san fran zlab xene januari high-dos parkinson gene therapi data expect soon januari pozi cohort failur shift focu rolonti bla accdecemb biotech sentiment week investorsjanuari updat head san fran anjanuari think upcom phase ii nash data look -januari call wamd market dynam -gen come kjanuari dose hbv clin trial stop co aim todecemb san fran takeaway sppijanuari data show encourag signal incomplet data invitedecemb san fran takeaway kzrjanuari meet upcom fda meet could move stocjanuari meet confid launch upcom bipoljanuari meet sf sobi updatejanuari collabor progress stock remain cheapjanuari meet sf updatejanuari in-lin guidanc light total surpris in-linejanuari equiti research
inform compani recommend
report pleas visit websit http //
javatar bluematrix com/sellside/disclosur action call
michael yee certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
biren amin certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
eun yang ph certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
mauri raycroft ph certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
chri howerton phd certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
jefferi llc act financi advisor nightstar therapeut plc announc acquisit biogen inc
jefferi llc act financi advisor kite pharma kite sale compani
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr amarin corpor
jefferi group llc make market secur adr axov gene therapi ltd
jefferi group llc make market secur adr biogen inc
jefferi group llc make market secur adr blueprint medicin corpor
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr fibrogen inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr intra-cellular therapi inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr spring bank pharmaceut inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
pleas see import disclosur inform page report
jefferi group llc make market secur adr vertex pharmaceut incorpor
jefferi group llc make market secur adr
jefferi group llc make market secur adr zai lab limit
jefferi group llc affili subsidiari benefici own common equiti
last month end prior month end report date later day recent month end
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic amarin corpor
within past twelv month amarin corpor client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
amarin corpor one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
aurinia pharmaceut inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic aurinia inc
within past twelv month inc client jefferi llc invest bank servic
provid
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic axov gene therapi ltd
within past twelv month axov gene therapi ltd client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
axov gene therapi ltd one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
pleas see import disclosur inform page report
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
karyopharm inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
logicbio inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
within past twelv month jefferi llc and/or affili receiv compens product servic
invest bank servic non-invest bank secur relat compens client servic provid neurocrin
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
relmada within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic relmada therapeut
within past twelv month relmada therapeut client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
relmada therapeut one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
pleas see import disclosur inform page report
